Matalińska, J.; Lipiński, P.F.J.; Kosson, P.; Kosińska, K.; Misicka, A.
In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity. Int. J. Mol. Sci. 2020, 21, 7738.
https://doi.org/10.3390/ijms21207738
AMA Style
Matalińska J, Lipiński PFJ, Kosson P, Kosińska K, Misicka A.
In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity. International Journal of Molecular Sciences. 2020; 21(20):7738.
https://doi.org/10.3390/ijms21207738
Chicago/Turabian Style
Matalińska, Joanna, Piotr F. J. Lipiński, Piotr Kosson, Katarzyna Kosińska, and Aleksandra Misicka.
2020. "In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity" International Journal of Molecular Sciences 21, no. 20: 7738.
https://doi.org/10.3390/ijms21207738
APA Style
Matalińska, J., Lipiński, P. F. J., Kosson, P., Kosińska, K., & Misicka, A.
(2020). In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity. International Journal of Molecular Sciences, 21(20), 7738.
https://doi.org/10.3390/ijms21207738